Market Cap

Vertex Pharmaceuticals Incorporated Market Capitalization:

$113.24 Billion

USD as of Jan. 1, 2025

business Vertex Pharmaceuticals Incorporated Company Profile

Vertex Pharmaceuticals Incorporated Main Stock Listing

NASDAQ: VRTX

Market Capitalization History of Vertex Pharmaceuticals Incorporated

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Samsung Biologics Co.,Ltd. $49.14 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Vertex Pharmaceuticals Incorporated market cap

Date Market Cap YoY Change
Jan. 1, 2025 $113.24 B 5.60%
Jan. 1, 2024 $107.23 B 44.66%
Jan. 1, 2023 $74.13 B 17.85%
Jan. 1, 2022 $62.90 B 6.10%
Jan. 1, 2021 $59.28 B 0.89%
Jan. 1, 2020 $58.76 B 18.93%
Jan. 1, 2019 $49.41 B 14.41%
Jan. 1, 2018 $43.18 B 94.33%
Jan. 1, 2017 $22.22 B -5.38%
Jan. 1, 2016 $23.49 B -17.60%
Jan. 1, 2015 $28.50 B 39.35%
Jan. 1, 2014 $20.45 B 76.51%
Jan. 1, 2013 $11.59 B 21.19%
Jan. 1, 2012 $9.56 B -4.99%
Jan. 1, 2011 $10.06 B 1.28%
Jan. 1, 2010 $9.94 B 16.19%
Jan. 1, 2009 $8.55 B 62.33%
Jan. 1, 2008 $5.27 B -42.40%
Jan. 1, 2007 $9.15 B -1.04%
Jan. 1, 2006 $9.24 B 251.23%
Jan. 1, 2005 $2.63 B 2.62%
Jan. 1, 2004 $2.56 B -28.40%
Jan. 1, 2003 $3.58 B -29.89%
Jan. 1, 2002 $5.11 B -70.67%
Jan. 1, 2001 $17.42 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Company Description

Vertex Pharmaceuticals Incorporated is a pharmaceuticals and biotherapeutics company. It notably produces drugs and genetic therapies for cystic fibrosis and other skin conditions, such as pain, sickle cell disease, beta-thalassemia, hormonal deficiencies, kidney diseases, Duchenne muscular dystrophy, and diabetes.

business Vertex Pharmaceuticals Incorporated Company Profile

Vertex Pharmaceuticals Incorporated Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Vertex Pharmaceuticals Incorporated has the following listings and related stock indices.


Stock: NASDAQ: VRTX

Stock: FSX: VX1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.